Financial Forecasts for Priceline and Hotel RevPAR Metrics (2016‑2017)
Summary
The passage contains only routine financial tables and analyst estimates for hotel occupancy, ADR, RevPAR, and Priceline earnings. It mentions no high‑profile individuals, government agencies, or susp Provides quarterly RevPAR growth rates for US and Europe hotels. Shows BofA Merrill Lynch earnings and revenue forecasts for Priceline through 2019. Mentions a PEG ratio and price target for Pricelin
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Ackrell Capital Cannabis OTC Market Valuation Table (2017)
The document is a financial listing of small OTC cannabis companies with market metrics. It contains no references to influential political figures, government agencies, or alleged misconduct, offerin Provides EV multiples and stock price discounts for over 40 cannabis firms. Compiled by Ackrell Capital, a FINRA/SIPC member. Data dated November 30, 2017.
Cannabis Investment Report – Private Company Funding Totals (2016‑2017 YTD)
The document lists aggregate capital raised by private cannabis‑related firms and a few deal specifics. It contains no references to high‑ranking officials, government agencies, foreign leaders, or al Total capital raised by private cannabis companies grew from $256 M in 2016 to $483 M YTD 2017. Number of deals increased from 65 to 102 in the same period. Largest disclosed private deals in 2017 we
Yelp financial performance and analyst estimates overview (Q1‑Q4 2016‑2017)
The passage contains only routine financial metrics, analyst forecasts, and user‑engagement data for Yelp. It does not mention any high‑profile individuals, government agencies, or controversial actio Commissions expense turned negative in Q4 2016. US mobile active users up 2% YoY; desktop users down 14% YoY. Revenue and EBITDA estimates slightly above consensus for 2017‑2018.
Ackrell Capital report shows modest capital raised by U.S. publicly traded cannabis companies in 2017
The passage provides only aggregate financial data on small, largely unprofitable cannabis firms with no mention of high‑profile individuals, government agencies, or illicit activity. It lacks specifi Only $268 million total equity and debt raised by listed cannabis firms in the 12‑month period endin Most companies had little to no revenue and were not profitable. A single large $317 million finan
Ackrell Capital Cannabis Company Financial Metrics Table
The document is a plain financial summary of cannabis companies listed on the Canadian Securities Exchange with no mention of influential actors, misconduct, or controversial transactions. It offers n Provides market cap, revenue, EBITDA, and valuation multiples for dozens of cannabis firms. Includes percentages of stock price below enterprise value. No names of political figures, government agenc
Bank of America Merrill Lynch price target updates for multiple banks
The document is a routine financial analyst table showing revised price targets for various banks. It contains no references to political figures, government agencies, foreign leaders, or alleged misc Lists current price, old price objective (PO), and new PO for dozens of banks. Provides analyst rating (Buy, Neutral, Underperform) and firm rating codes. Source cited as BofA Merrill Lynch Global Re
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.